Microbiological spectrum and antibiotic susceptibility pattern in more than 24-month-old children with urinary tract infection: A6-year retrospective, single center experience.
10.3345/kjp.2009.52.10.1147
- Author:
Jeong Hee KO
1
;
Jee Hyun LEE
;
Eun Jung SHIM
;
Do Jun CHO
;
Ki Sik MIN
;
Ki Yang YOO
;
Dae Hyoung LEE
;
Hee Jung KANG
Author Information
1. Department of Pediatrics, College of Medicine, Hallym University, Seoul, Korea. mdleedh@hallym.or.kr
- Publication Type:Original Article
- Keywords:
Urinary tract infection;
Children;
Antibiotic resistance
- MeSH:
Amikacin;
Ampicillin;
Anti-Bacterial Agents;
Aztreonam;
Cefotaxime;
Cefotetan;
Ceftriaxone;
Cefuroxime;
Cephalosporins;
Child;
Ciprofloxacin;
Drug Resistance, Microbial;
Escherichia coli;
Humans;
Imipenem;
Preschool Child;
Retrospective Studies;
Urinary Tract;
Urinary Tract Infections
- From:Korean Journal of Pediatrics
2009;52(10):1147-1152
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: To characterize the pathogens and their antibiotic susceptibilities in more than 24-month-old children with urinary tract infection (UTI) and to study the Escherichia coli antimicrobial susceptibility trend. METHODS: We retrospectively reviewed the record of more than 24-month-old children with UTI between January 2003 and December 2008. Positive results for 1 bacterial species with a colony count of > or =10(5) CFU/mL was considered statistically significant. We analyzed uropathogens and their antibiotic susceptibilities. To investigate E. coli antibiotic susceptibility trend, we compared 2 study periods (group A: 2003-2005 versus group B: 2006-2008) using the chi-square test for trend. RESULTS: In all, 63 bacterial isolates were identified in children with febrile UTI. The most common pathogen was E. coli (77.8%). There was no difference in the resistance patterns of uropathogens during the 2 study periods (P>0.05). Antibiotic susceptibility of the E. coli isolates to aztreonam, cefotetan, cefotaxime, ceftriaxone, cefepime, amikacin, and imipenem was >90% to trimethoprim/sulfamethoxazol, 49% and to ampicillin and ampicillin/sulbactam, 20-25%. Over the 2 study period, the E. coli susceptibilities to most antibiotics did not change: the susceptibility to cefuroxime increased from 74.1% to 95.5% (P=0.046) and that to ciprofloxacin increased from 59.3% to 86.4% (P=0.039). CONCLUSION: Empirical treatment with trimethoprim/sulfamethoxazole, ampicillin, and ampicillin/sulbactam alone appeared to be insufficient in childhood UTI because of the high resistance of E. coli and other gram-negative uropathogens. Antibiotics for empirical therapy should be selected based on the sensitivity and resistance pattern of uropathogens found in a particular region.
